For me I already place GMVD in the bottom draw. So I won't be rushed to sell. It's depending on company's growth. If it made into North America market well, then there's no reason to rush. Health market is very large compared to us. So the opportunity and demand is there. It's up to company to have the right products This's my LT investment.
IPO update, page-456
-
- There are more pages in this discussion • 1,114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)